Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. CTI BioPharma's Cost of Goods Sold for the
three
months ended in Mar. 2023 was $1.22 Mil. CTI BioPharma's Average Total Inventories for the quarter that ended in Mar. 2023 was $0.76 Mil.
CTI BioPharma's Inventory Turnover for the quarter that ended in Mar. 2023 was 1.62.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
CTI BioPharma's Days Inventory for the
three
months ended in Mar. 2023 was 56.29.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CTI BioPharma's Inventory-to-Revenue for the quarter that ended in Mar. 2023 was 0.03.
CTI BioPharma Inventory Turnover Historical Data
The historical data trend for CTI BioPharma's Inventory Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
CTI BioPharma's Days Inventory for the
three
months ended in Mar. 2023 is calculated as:
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CTI BioPharma's Inventory to Revenue for the quarter that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.
CTI BioPharma Inventory Turnover Related Terms
Thank you for viewing the detailed overview of CTI BioPharma's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
CTI BioPharma (CTI BioPharma) Business Description
CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CTIC has been successfully added to your 